OQRO

Feed Ask OQRO News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved OQRO MCP

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 5,786 NRIX derivative securities | OQRO

Home
Insider trades
Nurix Therapeutics
Officer exercised or converted 5,786 NRIX derivative securities

Insider trades

Insider trade

Officer exercised or converted 5,786 NRIX derivative securities

Traded Oct 2, 2026 · Filed Oct 2, 2026

NRINurix TherapeuticsNRIX

5,786
Shares · @ $8.72

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 2, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 2, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001817199-26-000032

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Oct 2, 2026, 9:21 PM UTC

Added to OQRO

Oct 7, 2026, 2:00 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Nurix Therapeutics, Inc.

Issuer CIK

1549595

Ticker

NRIX

Reporting person

Christine Ring

Relationship

Officer

Officer title

Chief Legal Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Oct 2, 2026

Transaction code

Shares / units

5,786

Price per share

$8.72

Acquired / disposed

Acquired (A)

Shares owned after

14,896

Ownership form

Direct

Amendment

Footnotes from the filing

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Around the same time

Christine Ring (Officer) plans to sell ~$135K of Nurix Therapeutics

Planned, from payFiled 5d ago

Christine Ring (Chief Legal Officer) sold ~$134K of Nurix Therapeutics

Planned saleFiled 5d ago

Christine RingChief Legal Officer

Filed 5d ago

5,786Derivative units

Traded Oct 2 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record